Diagnostic Challenges in Pediatric Fever of Unknown Origin: Combined Role of Ferritin and Fever Duration
Highlights
- Infectious and rheumatologic diseases are the primary causes for fever of unknown origin in children, while a notable subset of undefined cases resolves spontaneously without recurrence.
- Prolonged fever combined with elevated ferritin emerged as a combined predictor of non-infectious etiologies.
- A simple combination of prolonged fever duration and ferritin can provide an early, practical tool to differentiate non-infectious etiologies.
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Groups and Data Collection
2.2. Microbiological Evaluation
2.3. Biochemical and Hematological Evaluation
2.4. Statistical Analysis
3. Results
3.1. Patient Characteristics
3.2. Clinical Presentation
3.3. Etiologies
3.4. Laboratory Findings and Group Comparisons
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| FUO | Fever of unknown origin |
| CRP | C-reactive protein |
| ROC | Receiver operating characteristic |
| AUC | Area under the curve |
| CI | Confidence intervals |
| EBV | Epstein–Barr virus |
| PCR | Polymerase chain reaction |
| CGD | Chronic granulomatous disease |
| JIA | Juvenile idiopathic arthritis |
| HLH | Hemophagocytic lymphohistiocytosis |
| PID | Primary immune deficiency |
References
- Petersdorf, R.G.; Beeson, P.B. Fever of unexplained origin: Report on 100 cases. Medicine 1961, 40, 1–30. [Google Scholar] [CrossRef]
- Durack, D.T.; Street, A.C. Fever of unknown origin-reexamined and redefined. Curr. Clin. Top. Infect. Dis. 1991, 11, 35–51. [Google Scholar] [PubMed]
- Dhangar, P.; Panda, P.K.; Kant, R.; Gupta, R.; Dua, R.; Tiwari, A.; Saini, S.; Khoiwal, K.; Bahurupi, Y. Evaluating fever of unknown origin definitions in a tertiary care setting: Implications for diagnostic criteria revision. World J. Exp. Med. 2025, 15, 101388. [Google Scholar] [CrossRef]
- Wright, W.F.; Auwaerter, P.G. Fever and Fever of Unknown Origin: Review, Recent Advances, and Lingering Dogma. Open Forum Infect. Dis. 2020, 7, ofaa132. [Google Scholar] [CrossRef]
- Rienvichit, P.; Lerkvaleekul, B.; Apiwattanakul, N.; Pakakasama, S.; Rattanasiri, S.; Vilaiyuk, S. Prediction model for etiology of fever of unknown origin in children. Eur. J. Pediatr. 2025, 184, 429. [Google Scholar] [CrossRef]
- Antoon, J.W.; Peritz, D.C.; Parsons, M.R.; Skinner, A.C.; Lohr, J.A. Etiology and Resource Use of Fever of Unknown Origin in Hospitalized Children. Hosp. Pediatr. 2018, 8, 135–140. [Google Scholar] [CrossRef] [PubMed]
- Bouhmidi, M.; Babakhouya, A.; El Ouali, A.; Ghannam, A.; Rkain, M.; Benajiba, N. P074 Prolonged fever in children: Epidemiological and etiological profile in the eastern region of Morocco—About 119 cases. Rheumatology 2021, 60 (Suppl. 5), keab722.066. [Google Scholar] [CrossRef]
- Trapani, S.; Fiordelisi, A.; Stinco, M.; Resti, M. Update on Fever of Unknown Origin in Children: Focus on Etiologies and Clinical Approach. Children 2023, 11, 20. [Google Scholar] [CrossRef]
- Haidar, G.; Singh, N. Fever of Unknown Origin. N. Engl. J. Med. 2022, 386, 463–477. [Google Scholar] [CrossRef]
- Çelik, T.; Güzel, Y. Parents’ Knowledge and Management of Fever: “Parents versus Fever!”. Turk. Arch. Pediatr. 2024, 59, 179–184. [Google Scholar] [CrossRef]
- Henter, J.I. Hemophagocytic Lymphohistiocytosis. N. Engl. J. Med. 2025, 392, 584–598. [Google Scholar] [CrossRef]
- Kim, Y.S.; Kim, K.R.; Kang, J.M.; Kim, J.M.; Kim, Y.J. Etiology and clinical characteristics of fever of unknown origin in children: A 15-year experience in a single center. Korean J. Pediatr. 2017, 60, 77–85. [Google Scholar] [CrossRef]
- Hu, B.; Chen, T.M.; Liu, S.P.; Hu, H.L.; Guo, L.Y.; Chen, H.Y.; Li, S.Y.; Liu, G. Fever of unknown origin (FUO) in children: A single-center experience from Beijing, China. BMJ Open. 2022, 12, e049840. [Google Scholar] [CrossRef]
- Shoman, W.; Galal, A.; Elshishiny, A.M.; Hamza, E. Fever of unknown origin in pediatrics: Causes and clinical characteristics in a single centre experience. Gaz. Egypt. Pediatr. Assoc. 2024, 72, 65. [Google Scholar] [CrossRef]
- Demir, O.; Kılıç, M.Ç.; Kışla, R.E.; Çelik, Ü. Fever of Unknown Origin in Children: A Single Center Experience from Southern Türkiye. J. Pediatr. Inf. 2024, 18, 168–176. [Google Scholar] [CrossRef]
- L’Huillier, A.G.; Mardegan, C.; Cordey, S.; Luterbacher, F.; Papis, S.; Hugon, F.; Kaiser, L.; Gervais, A.; Posfay-Barbe, K.; Galetto-Lacour, A. Enterovirus, parechovirus, adenovirus, and herpes virus type 6 viremia in fever without source. Arch. Dis. Child. 2020, 105, 180–186. [Google Scholar] [PubMed]
- Erdem, H.; Baymakova, M.; Alkan, S.; Letaief, A.; Yahia, W.B.; Dayyab, F.; Kolovani, E.; Grgic, S.; Cosentino, F.; Hasanoglu, I.; et al. Classical fever of unknown origin in 21 countries with different economic development: An international ID-IRI study. Eur. J. Clin. Microbiol. Infect. Dis. 2023, 42, 387–398. [Google Scholar] [CrossRef]
- Ciftçi, E.; Ince, E.; Doğru, U. Pyrexia of unknown origin in children: A review of 102 patients from Turkey. Ann. Trop. Paediatr. 2003, 23, 259–263. [Google Scholar] [CrossRef] [PubMed]
- Öcal-Demir, S.; Kahraman, K.; Bozbeyoğlu, G.; Esen, F. Clinical Presentation of Cat Scratch Disease in Pediatric Patients—A Single-Center Study. Turk. Arch. Pediatr. 2024, 59, 574–579. [Google Scholar] [CrossRef] [PubMed]
- Tsujino, K.; Tsukahara, M.; Tsuneoka, H.; Ichihara, K.; Furuya, T.; Kawauchi, S.; Oga, A.; Sasaki, K. Clinical implication of prolonged fever in children with cat scratch disease. J. Infect. Chemother. 2004, 10, 227–233. [Google Scholar] [CrossRef]
- Sahin, S.; Hopurcuoglu, D.; Bektas, S.; Belhan, E.; Adrovic, A.; Barut, K.; Canpolat, N.; Caliskan, S.; Sever, L.; Kasapcopur, O. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center. Int. J. Rheum. Dis. 2019, 22, 132–139. [Google Scholar] [CrossRef] [PubMed]
- Kisla Ekinci, R.M.; Kilic Konte, E.; Akay, N.; Gul, U. Familial Mediterranean Fever in Childhood. Turk. Arch. Pediatr. 2024, 59, 527–534. [Google Scholar] [CrossRef]
- Baldo, F.; Erkens, R.G.A.; Mizuta, M.; Rogani, G.; Lucioni, F.; Bracaglia, C.; Foell, D.; Gattorno, M.; Jelusic, M.; Anton, J.; et al. PReS MAS/sJIA Working Party and Paediatric Rheumatology International Trial Organization. Current treatment in macrophage activation syndrome worldwide: A systematic literature review to inform the METAPHOR project. Rheumatology 2025, 64, 32–44. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Statler, V.A.; Marshall, G.S. Characteristics of Patients Referred to a Pediatric Infectious Diseases Clinic with Unexplained Fever. J. Pediatric Infect. Dis. Soc. 2016, 5, 249–256. [Google Scholar] [CrossRef]
- Weakley, K.E.; Marshall, G.S.; Statler, V.A. Long-term Health Outcomes of Patients Evaluated for Unexplained Fever in a Pediatric Infectious Diseases Clinic. J. Pediatric Infect. Dis. Soc. 2020, 9, 494–497. [Google Scholar] [CrossRef] [PubMed]
- Lou, D.; Song, Y. Clinical features of histiocytic necrotizing lymphadenitis in children. Eur. J. Pediatr. 2024, 183, 1333–1339. [Google Scholar] [CrossRef]
- Nihira, H.; Nakagawa, K.; Izawa, K.; Kawai, T.; Yasumi, T.; Nishikomori, R.; Nambu, M.; Miyagawa-Hayashino, A.; Nomura, T.; Kabashima, K.; et al. Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency. Scand. J. Rheumatol. 2018, 47, 170–172. [Google Scholar] [CrossRef]
- Jamee, M.; Khakbazan Fard, N.; Fallah, S.; Golchehre, Z.; Fallahi, M.; Shamsian, B.S.; Sharafian, S.; Chavoshzadeh, Z. Cernunnos defect in an Iranian patient with T-B+NK+ severe combined immunodeficiency: A case report and review of the literature. Mol. Genet. Genom. Med. 2022, 10, e1990. [Google Scholar] [CrossRef]
- Taha, D.; Boerkoel, C.F.; Balfe, J.W.; Khalifah, M.; Sloan, E.A.; Barbar, M.; Haider, A.; Kanaan, H. Fatal lymphoproliferative disorder in a child with Schimke immuno-osseous dysplasia. Am. J. Med. Genet. A 2004, 131, 194–199. [Google Scholar] [CrossRef] [PubMed]
| N (%) | ||
|---|---|---|
| Gender | Male | 47 (54%) |
| Female | 40 (46%) | |
| Age | >6 years | 54 (61.6%) |
| 6–12 years | 15 (17.4%) | |
| >12 years | 18 (21%) | |
| Duration of fever | 7–13 days | 49 (56%) |
| 14–20 days | 25 (28.7%) | |
| 21–27 days | 3 (3.4%) | |
| >28 days | 10 (11.4%) | |
| Complaints | Rash | 27 (31%) |
| Fatigue | 24 (27.5%) | |
| Muscle/joint pain | 22 (25.2%) | |
| Cough | 14 (16%) | |
| Weight loss | 13 (14.9%) | |
| Abdominal pain | 9 (10.3%) | |
| Night sweats | 8 (9.1%) | |
| Nausea-vomiting | 6 (6.8%) | |
| Sputum production | 6 (6.8%) | |
| Chest pain | 4 (4.6%) | |
| Physical Examination | Maculopapular rash | 27 (31%) |
| Hepatomegaly | 12 (13.7%) | |
| Cervical lymphadenopathy | 11 (12.6%) | |
| Oropharyngeal findings | 8 (9.1%) | |
| Splenomegaly | 7 (8%) | |
| Generalized lymphadenopathy | 4 (4.6%) | |
| Respiratory findings | 2 (2.2%) | |
| Cardiac murmur | 2 (2.2%) | |
| Etiology | Infectious | 37 (42.5%) |
| Inflammatory | 17 (19.5%) | |
| Unknown origin | 15 (17.2%) | |
| Miscellaneous | 13 (14.9%) | |
| Malignancy | 5 (5.9%) | |
| Treatment | Antibiotics | 31 (35.6%) |
| Corticosteroid | 16 (18.3%) | |
| Biological agent | 8 (9.1%) | |
| Intravenous immune globulin | 6 (6.8%) |
| Infectious | Adenovirus (8) |
| Brucellosis (5) | |
| Epstein- Barr Virus (5) | |
| Tuberculosis (4) | |
| Bartonellosis (2) | |
| Streptococcus pyogenes (2) | |
| Human herpesvirus 6 (1) | |
| Dural abscesses (1) | |
| Staphylococcus aureus (1) | |
| Cytomegalovirus (1) | |
| Inflammatory | Systemic juvenile idiopathic arthritis (7) |
| Kawasaki disease (5) | |
| Familial Mediterranean fever (2) | |
| Acute rheumatic fever (1) | |
| Takayasu arteritis (1) | |
| Miscellaneous | Chronic granulomatous disease (4) |
| Primary antibody deficiency (1) | |
| Immune dysregulation (2) | |
| Inflammatory bowel disease (1) | |
| Kikuchi Fujimoto disease (1) | |
| Propionic acidemia (1) | |
| Primary hemophagocytic lymphohistiocytosis (2) | |
| Malignancy | Neuroblastoma (2) |
| Acute lymphoblastic leukemia (1) | |
| Myelodysplastic syndrome (1) | |
| NK cell lymphoma (1) |
| Infectious | Inflammatory | Unknown | Miscellaneous | Malignancy | p | |
|---|---|---|---|---|---|---|
| Age (month) | 58 (10–192) | 72 (5–189) | 33 (6–193) | 60 (3–204) | 67.5 (48–109) | 0.72 * |
| Fever duration (day) | 10 (5–30) | 14 (8–30) | 14 (7–50) | 11 (9–40) | 14.5 (10–40) | 0.026 * |
| C-Reactive protein (mg/L) | 23 (0.6–216) | 107 (13–333) | 15.4 (1–165) | 25 (3–255) | 43.5 (5.5–79) | 0.003 * |
| Sedimentation rate (mm/h) | 30 (2–475) | 79 (27–124) | 13 (2–109) | 61 (3–91) | 63 (17–99) | 0.001 * |
| Hemoglobin (g/dL) | 10.6 (8–15) | 9.5 (8–12) | 11.3 (7.1–14.5) | 8.3 (8–13) | 9.65 (8–10) | 0.009 * |
| Total leucocyte count (/µL) | 9500 (1300–22,000) | 13,900 (2200–37,600) | 11,600 (3970–23,300) | 12,400 (4400–29,400) | 10,545 (4600–220,400) | 0.206 * |
| Neutrophil count (/µL) | 4000 (840–15,900) | 8400 (400–34,800) | 7500 (1500–15,500) | 6400 (600–18,500) | 5505 (2300–102,900) | 0.038 * |
| Lymphocyte count (/µL) | 3000 (600–13,600) | 2100 (640–8000) | 4000 (800–6300) | 3790 (600–13,200) | 3300 (1300–42,600) | 0.94 * |
| Platelet count (/µL) | 286,000 (18,200–761,000) | 509,000 (38,000–1,000,000) | 449,000 (159,000–853,000) | 332,000 (13,000–613,000) | 312,500 (35,000–833,000) | 0.044 * |
| Ferritin (ng/mL) | 142 (15–2120) | 750 (6–25.400) | 120 (38–387) | 286 (25–2943) | 254.5 (15–745) | 0.00 * |
| Aspartate aminotransferase IU/L | 58.9 ± 80.4 | 41.8 ± 32.4 | 28.3 ± 10.09 | 50.5 ± 53.8 | 43 ± 19.7 | 0.107 & |
| Alanine aminotransferase IU/L | 63.7 ± 134.9 | 36.7 ± 39.6 | 14.7 ± 8.2 | 29.2 ± 22.4 | 18.5 ± 8.7 | 0.035 & |
| Lactate dehydrogenase IU/L | 302 (178–825) | 289 (133–623) | 323 (171–387) | 361 (187–662) | 444 (192–1125) | 0.496 * |
| Fever Day | Sedimentation | Ferritin | CRP | Neutrophil | Hemoglobin | Platelet | |
|---|---|---|---|---|---|---|---|
| Inflammatory-Malignancy | 0.323 | 0.319 | 0.074 | 0.050 | 0.327 | 0.889 | 0.327 |
| Inflammatory-Infection | 0.108 | 0.038 | 0.000 | 0.001 | 0.002 | 0.010 | 0.017 |
| Inflammatory-Miscellaneous | 0.220 | 0.018 | 0.263 | 0.066 | 0.232 | 0.982 | 0.132 |
| Inflammatory-Unknown | 0.760 | 0.002 | 0.000 | 0.000 | 0.331 | 0.005 | 0.865 |
| Malignancy-Infection | 0.024 | 0.083 | 0.149 | 0.888 | 0.344 | 0.049 | 0.861 |
| Malignancy-Miscellaneous | 0.635 | 0.494 | 0.616 | 0.750 | 0.750 | 0.820 | 0.892 |
| Malignancy-Unknown | 0.507 | 0.533 | 0.094 | 0.243 | 0.846 | 0.011 | 0.302 |
| Infection-Miscellaneous | 0.009 | 0.226 | 0.018 | 0.5 | 0.137 | 0.059 | 0.907 |
| Infection-Unknown | 0.072 | 0.454 | 0.443 | 0.096 | 0.120 | 0.492 | 0.011 |
| Miscellaneous-Unknown | 0.540 | 0.241 | 0.014 | 0.124 | 0.961 | 0.092 | 0.075 |
| B | S.E. | Wald | df | Sig. | Exp(B) | 95% C.I. for EXP(B) | |||
|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||||
| Step 1 a | feverday | −0.090 | 0.039 | 5.301 | 1 | 0.021 | 0.914 | 0.846 | 0.987 |
| ferritin | −0.001 | 0.001 | 3.175 | 1 | 0.075 | 0.999 | 0.998 | 1.000 | |
| Constant | 1.334 | 0.575 | 5.376 | 1 | 0.020 | 3.797 | |||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Önal, P.; Sever, G.A.; Eren, B.A.; Kes, G.; Yücel, E.Ö.; Ocak, S.; Kıykım, A.; Şahin, S.; Çokuğraş, H.; Aygün, F.; et al. Diagnostic Challenges in Pediatric Fever of Unknown Origin: Combined Role of Ferritin and Fever Duration. Children 2025, 12, 1493. https://doi.org/10.3390/children12111493
Önal P, Sever GA, Eren BA, Kes G, Yücel EÖ, Ocak S, Kıykım A, Şahin S, Çokuğraş H, Aygün F, et al. Diagnostic Challenges in Pediatric Fever of Unknown Origin: Combined Role of Ferritin and Fever Duration. Children. 2025; 12(11):1493. https://doi.org/10.3390/children12111493
Chicago/Turabian StyleÖnal, Pınar, Gözde Apaydın Sever, Beste Akdeniz Eren, Gülşen Kes, Esra Özek Yücel, Süheyla Ocak, Ayça Kıykım, Sezgin Şahin, Haluk Çokuğraş, Fatih Aygün, and et al. 2025. "Diagnostic Challenges in Pediatric Fever of Unknown Origin: Combined Role of Ferritin and Fever Duration" Children 12, no. 11: 1493. https://doi.org/10.3390/children12111493
APA StyleÖnal, P., Sever, G. A., Eren, B. A., Kes, G., Yücel, E. Ö., Ocak, S., Kıykım, A., Şahin, S., Çokuğraş, H., Aygün, F., Kasapçopur, Ö., & Aygün, F. D. (2025). Diagnostic Challenges in Pediatric Fever of Unknown Origin: Combined Role of Ferritin and Fever Duration. Children, 12(11), 1493. https://doi.org/10.3390/children12111493

